A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Clinical trial NCT07209761 · RECRUITING
Trial details
- NCT number
- NCT07209761
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-16
- Primary completion
- 2027-05-28
- Enrollment
- 532
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.